SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension

Published:2022-05 Issue:5 Volume:66 Page:539-554
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Le Ribeuz Hélène¹²,Masson Bastien¹²,Capuano Véronique¹²³,Dutheil Mary¹²³,Gooroochurn Hans⁴,Boët Angèle¹²,Ghigna Maria-Rosa¹²³,De Montpreville Vincent⁴,Girerd Barbara¹²⁵,Lambert Mélanie¹²,Mercier Olaf¹²⁶,Chung Wendy K.⁷,Humbert Marc¹²⁵^ORCID,Montani David¹²⁵^ORCID,Antigny Fabrice¹²^ORCID

Affiliation:

1. Université Paris-Saclay, School of Medecine, Paris-Saclay University, Paris, France;

2. INSERM UMR_S 999, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue, Le Plessis-Robinson, France;

3. Hôptal Marie Lannelongue, Groupe Hospitalier Paris Saint-Joseph, Le Plessis-Robinson, France;

4. Department of Pathology, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France;

5. Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Respiratory and Intensive Care Medicine, Pulmonary Hypertension National Referral Center, Hôpital Bicêtre, Le Kremlin-Bicêtre, France;

6. Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Groupe Hospitalier Paris Saint-Joseph-Marie Lannelongue Hospital, 92350 Le Plessis-Robinson, France; and

7. Columbia University, New York, New York

Funder

Agence Nationale de la Recherche

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Link

https://www.atsjournals.org/doi/pdf/10.1165/rcmb.2021-0180OC

Reference58 articles.

1. Haemodynamic definitions and updated clinical classification of pulmonary hypertension

2. Epidemiology and treatment of pulmonary arterial hypertension